These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1283 related articles for article (PubMed ID: 37486927)
1. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study. Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927 [TBL] [Abstract][Full Text] [Related]
2. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study. Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506 [TBL] [Abstract][Full Text] [Related]
4. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study. Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735 [TBL] [Abstract][Full Text] [Related]
5. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study. Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907 [TBL] [Abstract][Full Text] [Related]
6. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Wan EYF; Chui CSL; Lai FTT; Chan EWY; Li X; Yan VKC; Gao L; Yu Q; Lam ICH; Chun RKC; Cowling BJ; Fong WC; Lau AYL; Mok VCT; Chan FLF; Lee CK; Chan LST; Lo D; Lau KK; Hung IFN; Leung GM; Wong ICK Lancet Infect Dis; 2022 Jan; 22(1):64-72. PubMed ID: 34411532 [TBL] [Abstract][Full Text] [Related]
7. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study. Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517 [No Abstract] [Full Text] [Related]
8. Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study. Kang W; Shami JJP; Yan VKC; Ye X; Blais JE; Li X; Lee VHF; Chui CSL; Lai FTT; Wan EYF; Wong CKH; Wong ICK; Chan EW J Hematol Oncol; 2022 May; 15(1):66. PubMed ID: 35590336 [TBL] [Abstract][Full Text] [Related]
9. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong. Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018 [TBL] [Abstract][Full Text] [Related]
10. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization. Wong CKH; Xiong X; Lau KTK; Chui CSL; Lai FTT; Li X; Chan EWY; Wan EYF; Au ICH; Cowling BJ; Lee CK; Wong ICK BMC Med; 2022 Mar; 20(1):119. PubMed ID: 35296305 [TBL] [Abstract][Full Text] [Related]
11. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. Wong CKH; Mak LY; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng WY; Cheng FWT; Yuen MF; Wong ICK J Hepatol; 2022 Nov; 77(5):1339-1348. PubMed ID: 35817224 [TBL] [Abstract][Full Text] [Related]
12. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185 [TBL] [Abstract][Full Text] [Related]
13. mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study. Wan EYF; Chui CSL; Mok AHY; Xu W; Yan VKC; Lai FTT; Li X; Wong CKH; Chan EWY; Lui DTW; Tan KCB; Hung IFN; Lam CLK; Leung GM; Wong ICK Drug Saf; 2022 Dec; 45(12):1477-1490. PubMed ID: 36184720 [TBL] [Abstract][Full Text] [Related]
14. Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines. Cheng FWT; Wong CKH; Qin SX; Chui CSL; Lai FTT; Li X; Wan EYF; Chan EW; Au CH; Ye X; Tang SCW; Wong ICK Nephrol Dial Transplant; 2023 Jan; 38(1):129-137. PubMed ID: 36367015 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection. Wong CKH; Lau KTK; Au ICH; Lau EHY; Cowling BJ Int J Antimicrob Agents; 2024 Mar; 63(3):107094. PubMed ID: 38272281 [TBL] [Abstract][Full Text] [Related]
16. Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong. Lui DTW; Xiong X; Cheung CL; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Chung MSH; Au ICH; Lee CH; Ip TP; Woo YC; Tan KCB; Wong CKH; Wong ICK J Bone Miner Res; 2024 May; 39(5):551-560. PubMed ID: 38477768 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study. Yan VKC; Cheng FWT; Chui CSL; Lai FTT; Wong CKH; Li X; Wan EYF; Wong JSC; Chan EWY; Wong ICK; Kwan MYW; Ip P Emerg Microbes Infect; 2023 Dec; 12(1):2185455. PubMed ID: 36852582 [TBL] [Abstract][Full Text] [Related]
18. Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients. Wong CKH; Lui DTW; Xiong X; Chui CSL; Lai FTT; Li X; Wan EYF; Cheung CL; Lee CH; Woo YC; Au ICH; Chung MSH; Cheng FWT; Tan KCB; Wong ICK BMC Med; 2022 Oct; 20(1):339. PubMed ID: 36229814 [TBL] [Abstract][Full Text] [Related]
19. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore. Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588 [TBL] [Abstract][Full Text] [Related]
20. Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron. Wei Y; Jia KM; Zhao S; Hung CT; Mok CKP; Poon PKM; Man Leung EY; Wang MH; Yam CHK; Chow TY; Guo Z; Yeoh EK; Chong KC JAMA Netw Open; 2023 Feb; 6(2):e2254777. PubMed ID: 36735253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]